Where does Endogenex's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Endogenex's 3 recorded funding rounds.

Premier Alternatives

Endogenex

Plymouth, MN · Founded 2017 · Privately Held (backing)

Developer of a medical device system designed to improve metabolic function in individuals with diabetes by resetting metabolic signalling in the small intestine. Endogenex is based in Plymouth, MN and was founded in 2017. It was valued at $218 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $190 million across 3 recorded rounds; the latest was a $69.6 million later-stage round in Jun 2024.

PMV mark · valuation

$218.0M

Oct 2026

Priced at

its later-stage round

Mar 2026

Total raised

$190.4M

Last round

Later Stage VC

Jun 2024

Cap table — not yet on record

Endogenex's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Endogenex with a free account

·The complete investor list: 11 names
·Watch Endogenex: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Endogenex

Where does Endogenex's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Endogenex's 3 recorded funding rounds.